Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
-
Shares outstanding
-
62,650,155
-
Total 13F shares
-
23,473,499
-
Share change
-
+2,508,640
-
Total reported value
-
$1,368,495,352
-
Put/Call ratio
-
163%
-
Price per share
-
$58.30
-
Number of holders
-
135
-
Value change
-
+$157,290,312
-
Number of buys
-
73
-
Number of sells
-
63
Institutional Holders of Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) as of Q4 2015
As of 31 Dec 2015,
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE) was held by
135 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,473,499 shares.
The largest 10 holders included
FMR LLC, VANGUARD GROUP INC, FRANKLIN RESOURCES INC, LORD, ABBETT & CO. LLC, Visium Asset Management, LP, JPMORGAN CHASE & CO, Redmile Group, LLC, ALLIANCEBERNSTEIN L.P., EAGLE ASSET MANAGEMENT INC, and BB BIOTECH AG.
This page lists
135
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.